Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 15 December 2006, Vol. 108, No. 13, pp. 3959-3960.

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Naik, U. P.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Naik, U. P.
Related Collections
Right arrowRelated Article in Blood Online
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow


InsideBlood

HEMOSTASIS

Comment on Pula et al, page 4035

Uncovering the dark side of PKC{delta}

Ulhas P. Naik

UNIVERSITY OF DELAWARE

In this issue of Blood, Pula and colleagues provide a novel mechanism for the negative regulatory role of platelet protein kinase C {delta} (PKC{delta}) that is independent of inside-out signaling, granular secretion, or early steps of GPVI signaling.

The initial step of agonist-induced platelet activation is platelet shape change, which is associated with intracellular calcium rise, phosphorylation of pleckstrin by PKC, and myosin light chain (MLC) by MLC kinase, followed by cytoskeletal rearrangement. Human platelets predominantly express 4 of the 12 known PKC isoforms.1 Although PKC{alpha}, beta, and {theta} have been shown to positively regulate platelet activation, PKC{delta} is unique in that it plays a positive as well as a negative regulatory role.2,3

In this issue, Pula and colleagues provide convincing evidence regarding the negative role of PKC{delta} in platelet aggregation and reveal a novel mechanism for regulation of actin and filopodia. Filopodia are membranous protrusions formed and supported by bundles of actin filaments and are followed by lamellipodia formation leading to platelet spreading.4 Vasodilator-stimulated phosphoprotein (VASP) regulates actin polymerization and hence filopodia formation primarily through its anticapping activity. VASP is a major substrate of protein kinase A, protein kinase G, and PKC, which phosphorylate it on Ser157, Ser239, and Thr278. Phosphorylation of VASP on Ser157 is required for its anticapping activity.5

In previous studies using pharmacological agents, it was suggested that PKC{delta} negatively regulates collagen-induced dense granule secretion.3 Using PKC{delta} knockout mice, Pula and colleagues show that negative regulation of platelet aggregation by PKC{delta} is independent of inside-out signaling, dense granule secretion, and early GPVI signaling. They also provide evidence that PKC{delta} physically interacts with VASP and inhibits VASP phosphorylation on Ser157 by classical PKC (cPKC) isoforms, thus suppressing actin polymerization and filopodia formation. The fact that cPKCs' ability to phosphorylate other platelet proteins is unaffected by the inhibition or absence of PKC{delta} suggests that PKC{delta} does not directly inhibit the activity of these enzymes. This workundoubtedly provides provocative new ideas and will inspire new studies investigating how association of VASP and PKC{delta} inhibit phosphorylation of VASP on Ser157. The evidence presented strongly suggests that the PKC{delta} activity is necessary for the observed negative regulation.Go


Figure 1
View larger version (127K):
[in this window]
[in a new window]

 
PKC{delta} negatively regulates filopodia formation in human platelets. See the complete figure in the article beginning on page 4035.

 
Future studies aimed at (1) the stoichiometry of PKC{delta} interaction with VASP, (2) how PKC{delta} activity is involved in inhibiting filopodia formation, (3) whether PKC{delta} activation is required for its interaction with VASP, (4) whether steric hindrance or conformational change resulting from PKC{delta} binding is responsible for decreased VASP phosphorylation on Ser157, and (5) whether PKC{delta} is constitutively associated with VASP in resting platelets or whether it becomes associated upon stimulation of platelets will be very interesting. Thus, this work, using a genetic approach, provides an intriguing avenue for further studies that might aid in design and development of novel therapeutic agents for the treatment of thrombotic disorders.

The author declares no competing financial interest. {blacksquare}

References

  1. Jaken S. Protein kinase C isozymes and substrates. Curr Opin Cell Biol. 1996;8: 168-173.[CrossRef][Medline] [Order article via Infotrieve]

  2. Moussazadeh M, Haimovich B. Protein kinase C-delta activation and tyrosine phosphorylation in platelets. FEBS Lett. 1998;438: 225-230.[CrossRef][Medline] [Order article via Infotrieve]

  3. Murugappan S, Tuluc F, Dorsam RT, Shankar H, Kunapuli SP. Differential role of protein kinase C delta isoform in agonist-induced dense granule secretion in human platelets. J Biol Chem. 2004;279: 2360-2367.[Abstract/Free Full Text]

  4. Naik UP, Naik MU. Association of CIB with GPIIb/IIIa during outside-in signaling is required for platelet spreading on fibrinogen. Blood. 2003;102: 1355-1362.[Abstract/Free Full Text]

  5. Barzik M, Kotova TI, Higgs HN, et al. Ena/VASP proteins enhance actin polymerization in the presence of barbed end capping proteins. J Biol Chem. 2005;280: 28653-28662.[Abstract/Free Full Text]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Related Article in Blood Online:

PKC{delta} regulates collagen-induced platelet aggregation through inhibition of VASP-mediated filopodia formation
Giordano Pula, Kai Schuh, Keiko Nakayama, Keiichi I. Nakayama, Ulrich Walter, and Alastair W. Poole
Blood 2006 108: 4035-4044. [Abstract] [Full Text] [PDF]




This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Naik, U. P.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Naik, U. P.
Related Collections
Right arrowRelated Article in Blood Online
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2006 by American Society of Hematology         Online ISSN: 1528-0020